theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Allergy & Immunology

HLH   

Questions discussed in this category


What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
2 Answers available

How do you utilize cytokine panels in your clinical practice?
Is there utility when classic inflammatory markers (ESR,CRP) or disease specific markers (C3, C4, dsDNA) do not correlate with patients disease activi...
1 Answer available

Should testing for genetic causes of HLH be performed in all patients with MAS or secondary HLH regardless of the patient's age?
2 Answers available

What are the best labs to trend improvement in HLH?
1 Answer available
19277145751467015429


Papers discussed in this category


Pediatric blood & cancer, 2011-01
Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality.

Arthritis & rheumatology (Hoboken, N.J.), 2023 Jul 24
The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS).

Related Topics in Allergy & Immunology

  • Breast Cancer
  • Hematologic Malignancies
  • Radiation Oncology
  • Pediatric Hematology/Oncology
  • Medical Oncology
  • Bone Marrow Transplant
  • Biologic Therapy/Immunobiology
  • Supportive Care
  • General Internal Medicine
  • Rheumatology

Copyright © 2025 theMednet
All Rights Reserved.